Skip to main content
OpenTrials
Completed

NCT Number: NCT05108792

Continuous Deep Sedation Until Death

This research is a descriptive observational study conducted in multicenter (intensive care and continuing care units) in France. All data collected is part of the patient record. The main objective is to describe the end-of-life sedative practices following a decision to limit or stop therapy in intensive care unit and continuing care unit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Terminal Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens, Amiens, France

Loading trial locations.

About this study

All participating sites will include last 10 consecutive major patients deceased following a decision to limit or stop therapeutics. The study include only data from patients died before January 1, 2020. In the case report form the following information will be entered:

  • the characteristics of the unit of intensive care or continuing care unit.
  • Patient Characteristics
  • Characteristics of sedative practices

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients at the time of death (>18years)
  • Died in intensive care or in continuing care unit
  • Patient died before January 1st, 2020.
  • Patients deceased following a decision to limit or stop therapeutics

Exclusion criteria

  • Patients who died of brain death or unexpected cardiac arrest at death of unsuccessful cardiopulmonary resuscitation
  • Patient who expressed during his lifetime his opposition to the use of his data for scientific research

Treatment and study plan

No intervention

Other

observational study, no intervention performed

Primary outcomes

  1. Description of end-of-life sedative practices

    Time frame: after patient death (before january 1st 2020)

    Information concerning end-of-life sedative practices are recorder in the CRF (treatments used, patient's and unit characteristics...)

Sponsors and collaborators

Lead sponsor

Société Française d'Anesthésie et de Réanimation

Other

Registry information

Official study title

Continuous Deep Sedation Until Death Following a Decision to Limit or Stop Treatment in Intensive Care and in Continuous Surveillance Units

Acronym: SPCMD-REA

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Nov 5, 2021
Registry last updated
Nov 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.